Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aleriom
AddedFeb 17, 2024
UpdatedJun 18, 2026
Aleriom

Aleriom

Angel

Aleriom, a Delaware-based SaaS and mobile app, connects international patients with top medical institutions.

HQ
Wilmington, DE, US
Founded
2023
Overview
Compare
Fundraising
Employees
Website

Aleriom, founded in Wilmington, Delaware, is a SaaS and mobile app platform dedicated to connecting international patients with top-tier medical institutions. The company's core mission is to facilitate access to high-quality medical and dental treatments abroad, ensuring that patients receive the best care possible. Aleriom offers a comprehensive service that includes booking medical procedures and managing travel-related needs, focusing primarily on the Latin American market.

Aleriom's Medical Board rigorously verifies all health professionals to ensure they meet high standards of education and experience. Notable achievements include establishing partnerships with leading medical institutions and successfully coordinating numerous international treatments. The platform has significantly impacted the medical tourism industry by providing a reliable and efficient way for patients to access world-class healthcare services abroad.

Aleriom - Similar Companies

AlemHealth logo

AlemHealth

alemhealth.com

VoyagerMed logo

VoyagerMed

voyagermed.com

Allermi logo

Allermi

SkyMedicus logo

SkyMedicus

ilomen logo

ilomen

Healarium logo

Healarium

healarium.com

Alpha Medical logo

Alpha Medical

helloalpha.com

MedRepublic logo

MedRepublic

pulseprotocol.com

DocFlight logo

DocFlight

AlloDoc logo

AlloDoc

doc.africa

AlyxHealth logo

AlyxHealth

alyxhealth.com

rightdevice logo

rightdevice

Docus logo

Docus

docus.ai

Fleri logo

Fleri

joinfleri.com

Mederva Health logo

Mederva Health

medervahealth.com

Aleriom - Quick Facts

Who are Aleriom's competitors?

Companies similar to Aleriom include AlemHealth, VoyagerMed, Allermi and SkyMedicus.

When was Aleriom founded?

Aleriom was founded in 2023.

Where is Aleriom's headquarters located?

Aleriom's headquarters is located in Wilmington, DE, US.

When was Aleriom's last funding round?

Aleriom's most recent funding round was for $100k (USD) in April 2023.

How much has Aleriom raised to-date?

As of Apr 14, 2023, Aleriom has raised a total of $100k (USD).

How many employees does Aleriom have?

Aleriom has 6 employees as of Feb 4, 2024.

Aleriom - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • Americas
Model
  • Platform
Revenue
  • SaaS
  • Transactional
Customer
  • Consumers
Main Product
  • Healthcare
  • Medical Tourism
Tags
  • Healthtech